In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...

-The Hindu   Dr. Manmohan Singh Prime Minister of India March 12, 2012 Dear Prime Minister, We welcome the tabling of a National Food Security Bill in the Lok Sabha as an important step towards the elimination of hunger and undernutrition in India. However, we feel that the Bill in its current form has some serious shortcomings. We are writing to propose a simpler and more effective framework for the Public Distribution System (PDS), which requires...

The myth that Fukushima radiation levels were too low to harm humans persists, a year after the meltdown.  A March 2, 2012 New York Times article quoted Vanderbilt University professor John Boice: “there’s no opportunity for conducting epidemiological studies that have any chance for success – the doses are just too low.”  Wolfgang Weiss of the UN Scientific Committee on the Effects of Atomic Radiation also recently said doses observed...

In a spate of recent cases in Punjab, information seekers are being turned away by public institutions on the ground that they are not covered under the RTI Act, and are not obliged to share information about their functioning. This despite the fact that almost all these institutions have received financial aid from the state government.   In nearly all such cases, the information seekers had to knock the doors of Information...

-The Economist   Nuclear power will not go away, but its role may never be more than marginal, says Oliver Morton THE LIGHTS ARE not going off all over Japan, but the nuclear power plants are. Of the 54 reactors in those plants, with a combined capacity of 47.5 gigawatts (GW, a thousand megawatts), only two are operating today. A good dozen are unlikely ever to reopen: six at Fukushima Dai-ichi, which suffered...